Volu-Sol
Generated 5/10/2026
Executive Summary
Volu-Sol is a privately-held manufacturer of diagnostic stains, reagents, and consumables for clinical and veterinary laboratories, with a history dating back to 1970. Based in Salt Lake City, Utah, the company specializes in hematology, histology, cytology, and microbiology products, and is also a significant supplier of ethanol. As a certified Women's Business Enterprise (WBE), Volu-Sol serves a niche but essential market, with a reputation for quality and reliability. However, the company operates in a mature industry with limited near-term growth catalysts, and its private status means limited visibility into financials or strategic initiatives. While stable, Volu-Sol appears to be a slow-growth entity with minimal disruption potential in the drug delivery or medical device spaces.
Upcoming Catalysts (preview)
- Q3 2026Launch of new histology/cytology reagent line60% success
- Q4 2026Expansion into veterinary diagnostic markets50% success
- TBDStrategic partnership or distribution agreement40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)